# 3915
SAGE, the Strategic Advisory Group of Experts on Immunizations, advises the WHO (World Health Organization) on policies and strategies for vaccination around the world.
Earlier today, the WHO released a vaccination Briefing note based on SAGE’s latest recommendations. (see WHO Briefing Note # 14: Vaccine Policies And Strategies)
Helen Branswell, ace medical reporter for The Canadian Press, untangles some of the complexities of this SAGE advice, including a reversal of an earlier recommendation that unadjuvanted vaccines be provided to pregnant women whenever possible.
As always with a Branswell report, it’s worth taking the time to read the whole thing.
Single H1N1 shot sufficient, pregnant women can use adjuvanted vaccine: WHO
By Helen Branswell Medical Reporter (CP)
A single dose of H1N1 vaccine should be adequate for all age groups, even very young children, and pregnant women should feel free to use vaccine containing adjuvant, an expert committee that advises the World Health Organization on vaccine issues reported Friday.
The group, known by the acronym SAGE, said vaccines containing boosting additives called adjuvants and vaccines that are adjuvant-free appear to be equally safe and there is no need to recommend pregnant women get the latter on a preferential basis.
"This is based on the fact that the safety profiles of adjuvanted vaccine and the non-adjuvanted vaccine are very similar, and the fact that the non-adjuvanted vaccine has been recommended for pregnant women for many, many years," Dr. Marie-Paule Kieny, director of the WHO's initiative for vaccine research, said in reporting on the recommendations of the panel.
"So there is no reason, in SAGE's view, to distinguish between both types of vaccines."
Related Post:
- NEJM: Adjuvanted Flu Vaccine Found Effective In Children
- Pediatrics: Effectiveness Of A Single Adjuvanted Pandemic Flu Shot In Children
- BMJ: Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine
- Lancet: Immunogenicity and safety Of Adjuvanted Flu Vaccines
- BMJ: Immunogenicity Of Adjuvanted vs. Unadjuvanted H1N1 Vaccines
- Novartis To Open Next Generation Vaccine Plant In NC
- Referral: Fergus Walsh Pandemrix Vaccine Q&A
- Canada Purchases Unadjuvanted Vaccine From CSL
- Helen Branswell’s Q&A On Adjuvants
- Branswell Reports On Canada’s Unadjuvanted Vaccine Purchase
- David Dobbs Examines The Adjuvant Controversy
- Branswell: Feds Between Rock & Hard Place On Vaccines
- Canada To Offer Unadjuvanted Vaccine To Pregnant Women
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Branswell On Flu Vaccine Matches
- Flu Vaccine Still Available, But Spot Shortages Exist
- Study: Self-Administered Vaccines In Adults
- Egypt: A Paltry Poultry Vaccine
- Lancet: Low Flu Vaccine Effectiveness
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- AAP Endorses SAGE Recommendations Keeping Thimerosal In Vaccines
- NIVW 2012
- Study Supports Safety Of Tdap Vaccine In Older Patients
- JAMA: Waning Pertussis Vaccine Effectiveness Over Time
- Revisiting The Numbers Racket
- Of Pregnancy, Flu & Autism
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- CMAJ On Mandatory Flu Shot For HCWs
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- The UK’s Whooping Cough Outbreak
- Peter Sandman On the CCIVI Vaccine Report
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Vietnam Reports Progress On New Bird Flu Vaccine
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- NPM12: Giving Preparedness A Shot In The Arm
- Yes, We Have No Pandemic . . .
- Branswell On Flu Vaccine Matches
- mBio: Coronavirus Has An Affinity For Multiple Hosts
- Branswell On Expanded Surveillance For The Coronavirus
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- SARS Virus Placed On Select Agents List
- Branswell Updates The Novel Coronavirus Story
- Osterholm: Time To Close The Pig Barns
- Branswell On Lifting The H5N1 Research Moratorium
- Pediatrics: Low Uptake Of Flu Vaccine Among Toddlers In Ontario
- NSABB Clears H5N1 Studies For Publication
- NSABB To Re-examine H5N1 Research Risks
- Branswell: WHO Hopes H5N1 Studies Can Be Published By Summer
- Branswell On The Transmissibility Of The H3N2v Virus
- Branswell On the CFR Of H5N1
- Eurosurveillance: Older People May Be Susceptible To The H3N2v Virus
- WHO: Will Host H5N1 Talks In Geneva
- Branswell On The Research Moratorium
- Branswell: WHO on H5N1 Research Controversy
- Publish or Perish The Thought?
- Three Would Make For A Crowded Viral Field
- Branswell: PLoS One Study On Adverse Reactions To MMR Vaccine
- Branswell On The New trH3N2 Flu Virus
- CIDRAP: New Details In The trH3N2 Story
- Branswell On The WHO Response To trH3N2
- More Details On The trH3N2 Story
Widget by [ Iptek-4u ]